BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26702489)

  • 1. [Secondary TFE3-associated renal cell carcinoma in a child treated for Ewing sarcoma].
    Fedhila Ben Ayed F; Rhayem S; Doghri R; Ben Hassine L; Khemiri M; Mrad K; Bellagha I; Barsaoui S
    Arch Pediatr; 2016 Feb; 23(2):171-5. PubMed ID: 26702489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma.
    Onder AM; Teomete U; Argani P; Toledano S; Zilleruelo G; Rodriguez MM
    Pediatr Nephrol; 2006 Oct; 21(10):1471-5. PubMed ID: 16807766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation Renal Cell Carcinoma in a Child Previously Treated for Infantile Fibrosarcoma.
    Ma J; Pan C; Yin M
    Pediatr Dev Pathol; 2018; 21(4):418-422. PubMed ID: 28478739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
    Song HC; Sun N; Zhang WP; He L; Fu L; Huang C
    J Pediatr Surg; 2014 Apr; 49(4):539-42. PubMed ID: 24726108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review.
    He J; Chen X; Gan W; Zhu B; Fan X; Guo H; Jia R
    Future Oncol; 2015; 11(24):3243-52. PubMed ID: 26169997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preliminary experiences of translocation renal cell carcinoma and literature review.
    Su HH; Sung MT; Chiang PH; Cheng YT; Chen YT
    Kaohsiung J Med Sci; 2014 Aug; 30(8):402-8. PubMed ID: 25002378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiT family translocation-associated (TFE3 positive) renal cell carcinoma of childhood.
    Katiyar R; U Patne SC; Chowdhary S
    Indian J Pathol Microbiol; 2018; 61(4):620-622. PubMed ID: 30303168
    [No Abstract]   [Full Text] [Related]  

  • 8. Translocation carcinomas of the kidney after chemotherapy in childhood.
    Argani P; Laé M; Ballard ET; Amin M; Manivel C; Hutchinson B; Reuter VE; Ladanyi M
    J Clin Oncol; 2006 Apr; 24(10):1529-34. PubMed ID: 16575003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma associated with TFE3 gene fusion in an elderly woman.
    LaGrange CA; Lele SM; Strup SE
    Urology; 2007 Sep; 70(3):590.e11-2. PubMed ID: 17905124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric renal cell carcinoma.
    Sausville JE; Hernandez DJ; Argani P; Gearhart JP
    J Pediatr Urol; 2009 Aug; 5(4):308-14. PubMed ID: 19443274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
    Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
    Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of Xp11.2 translocation renal cell carcinoma.
    Lim B; You D; Jeong IG; Kwon T; Hong S; Song C; Cho YM; Hong B; Hong JH; Ahn H; Kim CS
    Korean J Urol; 2015 Mar; 56(3):212-7. PubMed ID: 25763125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 13-year-old female with Xp11.2 translocation renal cell carcinoma; the first case diagnosed at Siriraj Hospital.
    Hanamornroongruang S; Treetipsatit J; Pongtanakul B; Seangchai N
    J Med Assoc Thai; 2012 Jul; 95(7):964-8. PubMed ID: 22919994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
    Winarti NW; Argani P; De Marzo AM; Hicks J; Mulyadi K
    Int J Surg Pathol; 2008 Jan; 16(1):66-72. PubMed ID: 18203790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma with MiTF/TFE3 translocation in children: report of a case at the stage of lymph node involvement.
    Fall B; Sarr A; Sow Y; Diao B
    Afr J Paediatr Surg; 2011; 8(3):317-9. PubMed ID: 22248899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
    Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C
    Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype.
    Kato H; Kanematsu M; Yokoi S; Miwa K; Horie K; Deguchi T; Hirose Y
    J Magn Reson Imaging; 2011 Jan; 33(1):217-20. PubMed ID: 21182142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of xp11.2 translocation renal cell carcinoma].
    Horie K; Kikuchi M; Miwa K; Minamidate Y; Yokoi S; Nakano M; Deguchi T; Ehara H; Asano N; Hirose Y
    Hinyokika Kiyo; 2011 Mar; 57(3):129-33. PubMed ID: 21586884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
    Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X
    Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.